Success Of Breast Cancer Trial Boosts Oncology Credentials Of AstraZeneca
AstraZeneca said its Enhertu cancer medicine has been demonstrated to assist women with a kind of breast cancer that has limited treatment choices, potentially opening the door to a much bigger patient population. Alongside low levels of a protein known as HER2, Enhertu extended life and reduced the spread of metastatic breast cancer, according to…









